N/A
Manufactured by WG Critical Care, LLC
80,205 FDA adverse event reports analyzed
Last updated: 2026-04-14
CALCIUM GLUCONATE is a medication tracked in the FDA Adverse Event Reporting System (FAERS), manufactured by WG Critical Care, LLC. The most commonly reported adverse reactions for CALCIUM GLUCONATE include DRUG INEFFECTIVE, PAIN, FATIGUE, OFF LABEL USE, RHEUMATOID ARTHRITIS. This page provides a comprehensive breakdown of reported side effects, safety signals, patient demographics, and AI-powered safety analysis for CALCIUM GLUCONATE.
Out of 11,608 classified reports for CALCIUM GLUCONATE:
The FDA classifies an adverse event as “serious” if it results in death, hospitalization, disability, congenital anomaly, or requires intervention to prevent permanent damage.
Demographics reflect voluntary FDA adverse event reporting patterns and may not represent the full patient population.
This profile reflects 80,205 FDA FAERS reports that mention CALCIUM GLUCONATE. Reporting is voluntary and does not prove that the drug caused any listed event.
Frequently reported terms in FAERS include DRUG INEFFECTIVE, PAIN, FATIGUE, OFF LABEL USE, RHEUMATOID ARTHRITIS, NAUSEA. Rankings reflect reporting volume in this dataset, not confirmed side effect rates in the general population.
Labeling and FAERS entries often list WG Critical Care, LLC in connection with CALCIUM GLUCONATE. Always verify the specific product and NDC with your pharmacist.